Design and evaluation of glutathione responsive glycosylated camptothecin nanosupramolecular prodrug
A novel tumor-targeted glutathione responsive Glycosylated-Camptothecin nanosupramolecular prodrug (CPT-GL NSp) was designed and fabricated via a disulfide bond. The effects of glycoligand with different polarities on solubility, self-assembly, stability, cellular uptake, and glutathione responsive...
Main Authors: | Wenhua Li, Zhong Chen, Xiaoying Liu, Mingming Lian, Haisheng Peng, Changmei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2021.1977424 |
Similar Items
-
Reactive oxygen species activated by mitochondria-specific camptothecin prodrug for enhanced chemotherapy
by: Zhaopei Guo, et al.
Published: (2022-10-01) -
Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing
by: Mingtao Ao, et al.
Published: (2021-10-01) -
Glutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy
by: Lingpu Zhang, et al.
Published: (2023-01-01) -
Prodrug Approach for Increasing Cellular Glutathione Levels
by: Ivana Cacciatore, et al.
Published: (2010-03-01) -
An Orally Bioavailable (Mice) Prodrug of Glutathione
by: Daune L. Crankshaw, et al.
Published: (2021-06-01)